Mosaic ImmunoEngineering (CPMV) Enterprise Value (2010 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Enterprise Value of -$72.0 for Q1 2026, up 99.92% year-over-year from -$36.02 in Q1 2025, and up 98.01% quarter-over-quarter from -$3622.0 in Q4 2025.
Mosaic ImmunoEngineering (CPMV) Enterprise Value (2010 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Enterprise Value history runs 17 years deep, the most recent figure standing at -$72.0 for Q1 2026.
- In Q1 2026, Enterprise Value rose 99.92% year-over-year to -$72.0; the TTM figure through Mar 2026 stood at -$72.0 (up 99.92% YoY), while the FY2025 annual figure was -$3622.0, up 96.85% from the prior year.
- Enterprise Value for Q1 2026 stood at -$72.0, up from -$3622.0 in the prior quarter.
- The five-year high for Enterprise Value was -$72.0 in Q1 2026, with the low at -$384137.0 in Q3 2022.
- The 5-year median for Enterprise Value is -$115019.0 (2024), against an average of -$144185.3.
- The sharpest annual moves came in 2025 and 2026: Enterprise Value slumped 1335.0% in 2025, then surged 99.92% in 2026.
- Mosaic ImmunoEngineering's Enterprise Value stood at -$220645.0 in 2022, then increased by 29.22% to -$156178.0 in 2023, then increased by 26.35% to -$115019.0 in 2024, then surged by 96.85% to -$3622.0 in 2025, then jumped by 98.01% to -$72.0 in 2026.
- Business Quant data shows CPMV's Enterprise Value at -$72.0 in Q1 2026, -$3622.0 in Q4 2025, and -$31761.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 2.12 Bn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | -72.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -72.00 |
| Dec 31, 2025 | -3,622.00 |
| Sep 30, 2025 | -31,761.00 |
| Jun 30, 2025 | -53,583.00 |
| Mar 31, 2025 | -85,930.00 |
| Dec 31, 2024 | -115,019.00 |
| Sep 30, 2024 | -5,736.00 |
| Jun 30, 2024 | -3,734.00 |
| Mar 31, 2024 | -65,039.00 |
| Dec 31, 2023 | -156,178.00 |
| Sep 30, 2023 | -252,898.00 |
| Jun 30, 2023 | -362,970.00 |
| Mar 31, 2023 | -125,777.00 |
| Dec 31, 2022 | -220,645.00 |
| Sep 30, 2022 | -384,137.00 |
| Jun 30, 2022 | -205,994.00 |
| Mar 31, 2022 | -378,055.00 |
| Dec 31, 2021 | -226,142.00 |
| Sep 30, 2021 | -393,121.00 |
| Jun 30, 2021 | -582,304.00 |